Welcome to our dedicated page for Piper Sandler Co`S SEC filings (Ticker: PIPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Piper Sandler Companies (NYSE: PIPR) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As an investment bank and institutional securities firm, Piper Sandler uses SEC filings to report its financial results, describe its operations and comply with ongoing reporting obligations.
Recent Form 8-K filings for Piper Sandler reference Item 2.02 – Results of Operations and Financial Condition, noting the release of financial results for specific fiscal quarters and directing readers to accompanying press releases furnished as exhibits. These current reports complement the firm’s earnings announcements and conference calls, providing an official record of quarterly performance.
On this page, you can access Piper Sandler’s 8-K current reports and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and other relevant filings. Stock Titan’s AI features are designed to highlight key sections, explain technical language and surface important points about advisory and capital markets activities, segment performance and risk disclosures as presented by the company in its filings.
For users interested in governance and ownership information, this page also serves as a starting point to locate proxy materials and insider transaction reports such as Form 4, when filed. Real-time updates from EDGAR combined with AI-generated overviews can help investors and researchers quickly understand what Piper Sandler reports in each document, without reading every page in detail.
Piper Sandler Companies’ President Debbra L. Schoneman reported an option exercise and related stock sales. On February 11, 2026, she exercised an employee stock option for 5,240 shares of common stock at $99 per share. The exercise increased her direct common stock holdings before subsequent sales.
That same day, she sold 81 shares of common stock at a weighted average price of $350.03, and separately sold 5,159 shares at $351.01 in open-market transactions. Following these trades, she directly owned 2,896 shares and indirectly held 56,264 shares through revocable living trusts for which she and her spouse serve as co‑trustees.
Piper Sandler Companies has a shareholder who intends to sell up to 7,500 shares of its common stock under Rule 144. The planned sale, through Charles Schwab & Co., Inc. on or about 02/11/2026 on the NYSE, has an aggregate market value of $2,632,461.00.
The 7,500 shares were acquired on 02/11/2026 via an employee stock option exercise from Piper Sandler Companies, using a broker payment for a cashless exercise. The filer represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Piper Sandler Companies reported a record fourth quarter and a strong full year 2025, driven mainly by advisory and investment banking. Net revenues reached $666.1 million in Q4, up 39% from Q3 and 38% from a year earlier. For 2025, net revenues were $1.90 billion, a 24% increase.
Full-year net income attributable to Piper Sandler rose to $281.3 million, with diluted EPS of $15.82, up 54% from 2024. On an adjusted basis, 2025 net income was $318.1 million and adjusted diluted EPS $17.74, both significantly higher than the prior year.
The board declared a $5.00 per-share special dividend and a regular quarterly dividend of $0.70, bringing the total 2025 dividend to $7.70 per share, or 43% of adjusted net income. The company returned $239 million to shareholders in 2025 through dividends and share repurchases.
Piper Sandler also approved a four-for-one forward stock split of its common stock. The amendment to increase authorized shares and effect the split is expected to be effective at 4:30 p.m. Eastern Time on March 23, 2026, with trading on a split-adjusted basis beginning March 24, 2026.
Piper Sandler Companies director reports stock award. Director Stuart Essig reported receiving 175 shares of Piper Sandler Companies common stock on February 4, 2026. The shares were acquired at a price of $0 per share, bringing his directly held beneficial ownership to 175 common shares after the transaction.
Piper Sandler Companies filed an initial insider ownership report for director Stuart Essig. The filing shows that Essig beneficially owns 0 shares of Piper Sandler common stock in direct form as of the event date. No derivative securities are reported.
Piper Sandler Companies appointed Stuart M. Essig to its Board of Directors effective February 4, 2026, for an initial term ending at the 2026 annual meeting of shareholders. His election increases the Board size from nine to ten directors, and he will serve on the Audit Committee.
Essig previously served as chief executive officer of Integra LifeSciences Corporation from 1997 to 2012 and has been chairman of its board since 2012, including as executive chairman from 2024 to 2025. He is also a director of IDEXX Laboratories. For his Board service in 2026, he will receive a prorated $100,000 cash retainer, a $60,000 initial equity grant, and a $150,000 annual equity grant after the 2026 annual shareholders’ meeting.
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 2,128,150 shares of Piper Sandler Cos common stock, representing 12.03% of the class as of 12/31/2025. Vanguard reports shared voting power over 140,426 shares and shared dispositive power over all 2,128,150 shares, with no sole voting or dispositive power.
The filing explains that Vanguard’s clients, including registered investment companies and other managed accounts, have the right to receive dividends and sale proceeds on these shares, with no single client holding more than 5% of the class. Vanguard states the holdings are in the ordinary course of business and not for the purpose of changing or influencing control. It also notes an internal realignment effective 01/12/2026, after which certain subsidiaries may report beneficial ownership on a disaggregated basis.
Piper Sandler Companies executive Jean-Paul M. Peltier, Global Co-Head IB and Cap Mkts, has filed an initial ownership report. The Form 3 shows that he beneficially owns 36,024 shares of Piper Sandler common stock, held in direct form. The reporting date for this ownership position is 01/09/2026. This is a disclosure of existing holdings rather than a record of a new stock purchase or sale.
Piper Sandler Companies director defers fees into stock units
A director of Piper Sandler Companies reported a routine compensation-related transaction. On 12/31/2025, the director accrued 75 shares of phantom stock at a price of $0 by electing to defer quarterly director cash retainer fees into stock-based units instead of taking cash. After this transaction, the director beneficially owned 25,525 shares of Piper Sandler common stock in total on a direct basis.
The phantom stock will be paid out in Piper Sandler common shares on the last day of the year in which the director’s board service ends, aligning part of the director’s compensation with the company’s long-term share performance.
Piper Sandler Companies director Philip E. Soran reported a routine change in his holdings. On 12/31/2025, he acquired 75 shares of phantom stock at a price of $0, reflecting his election to defer quarterly director cash retainer fees.
After this transaction, he beneficially owned 19,330 shares of common stock in total. The 75 phantom shares will be paid out in Piper Sandler common stock on the last day of the year in which his service as a director ends.